Recurrent Pyelonephritis in Quadriplegia: Rethinking Oral Cefdinir in the Presence of Nephrolithiasis

Key Points

• Oral cefdinir shows favorable outcomes in managing recurrent pyelonephritis.
• The study reports improved results in 85% of patients treated with cefdinir despite nephrolithiasis.
• Analysis of patient records reveals a significant link between nephrolithiasis and recurrent urinary tract infections.
• These findings highlight the need for updated treatment protocols in quadriplegia patients with urinary complications.